55.1
[1]. B H Lauterburg, et al. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans. J Pharmacol Exp Ther. 1985 Dec;35(3):566-7.
[]. B K Sinha, et al. Activation of hydrazine derivatives to free radicals in the perfused rat liver: a spin-trapping study. Biochim Biophys Acta. 1987 May 19;94():61-9.
[3]. Feng Li, et al. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy. Nat Med. 13 Apr;19(4):418-.
[4]. Ganglong Yang, et al. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy. J Proteome Res. 15 Feb 6;14():639-53.
[5]. Kyoung-Jin Kim, et al. Stable isotopic labeling-based quantitative targeted glycomics (i-QTaG). Biotechnol Prog. 15 May-Jun;31(3):84-8.
H31-H315-H319-H341-H351
P64-P7-P8-P3+P35-P33-P36-P45-P51
GHS6,GHS8
811